Rader is one of two scientists in the cardiovascular area to be granted this honor in 2006; other grant areas include: cancer, nutrition, neuroscience, infectious disease, metabolic diseases, and synthetic organic chemistry. A total of $6 million is being given to support cutting-edge biomedical research at twelve institutions around the world.
Rader, a physician-scientist, is a leader in the field of preventive cardiovascular medicine, cholesterol metabolism and atherosclerosis. He is recognized for his translational research in applying basic research in pathways of cholesterol metabolism and atherosclerosis to the development of new therapeutic approaches to reduce heart disease risk. He is especially well known for his work in novel approaches to boosting HDL (good cholesterol) levels and function.
At Penn, Rader directs the General Clinical Research Center, is Associate Director of the Institute for Translational Medicine and Therapeutics, and is Director of Penn's Lipid/Atherosclerosis/Cardiovascular Metabolism Research Unit of the Cardiovascular Institute and the Institute for Diabetes, Obesity and Metabolism. Clinically, he is Director of Preventive Cardiovascular Medicine at UPHS and recognized as an outstanding clinician.
In commenting on Rader's selection, Michael Parmacek, MD, Chief of Cardiovascular Medicine at Penn, noted, "This honor is well deserved and recognizes the many significant contributions that Dr. Rader has made over the past decade related to the prevention of heart disease. Dr. Rader is a role model for other researchers by demonst
'"/>
Contact: Susanne Hartman
susanne.hartman@uphs.upenn.edu
215-349-5964
University of Pennsylvania School of Medicine
6-Apr-2006